CSCI.TO · COSCIENS Biopharma Inc.
Canada · RS rating 97 · As of 2026-10-14
| Price | 9.60 CAD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 97 / 84 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 46 / 49 / 35 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | -102.2% |
| Sales growth Q/Q | +66.5% |
| Distance from 52-week high | +25.8% |
| Market cap (USD) | $6.7M |